{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T21:59:29Z","timestamp":1788731969219,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB TRR219"],"award-info":[{"award-number":["SFB TRR219"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010578","name":"Deutsche Gesellschaft f\u00fcr Kardiologie-Herz und Kreislaufforschung.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010578","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ahj.2021.05.015","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T09:24:42Z","timestamp":1622107482000},"page":"90-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications"],"prefix":"10.1016","volume":"239","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4425-549X","authenticated-orcid":false,"given":"Felix","family":"Mahfoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland E.","family":"Schmieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin D.","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Blankestijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Persu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim A.","family":"Fischell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Parise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kandzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2021.05.015_bib0001","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: analysis of worldwide data","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2021.05.015_bib0002","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1161\/CIRCULATIONAHA.114.010676","article-title":"Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals","volume":"130","author":"Egan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.05.015_bib0003","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.117.032582","article-title":"Potential US Population Impact of the 2017 ACC\/AHA High Blood Pressure Guideline","volume":"137","author":"Muntner","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.05.015_bib0004","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0140-6736(17)32281-X","article-title":"Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomized, sham-controlled, proof-of-concept trial","volume":"390","author":"Townsend","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2021.05.015_bib0005","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/S0140-6736(18)31082-1","article-title":"Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial","volume":"391","author":"Azizi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2021.05.015_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)30951-6","article-title":"Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial","volume":"391","author":"Kandzari","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2021.05.015_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30554-7","article-title":"Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial","author":"B\u00f6hm","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2021.05.015_bib0008","doi-asserted-by":"crossref","first-page":"281","DOI":"10.36076\/ppj\/2019.19.281","article-title":"The effectiveness of alcohol vs phenol based splanchnic nerve neurolysis for the treatment of intra-abdominal cancer pain","volume":"19","author":"Koyyalagunta","year":"2016","journal-title":"Pain physician"},{"key":"10.1016\/j.ahj.2021.05.015_bib0009","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/eujp.2001.0269","article-title":"Neurolytic blockade of the obturator nerve for intractable spasticity of adductor thigh muscles","volume":"6","author":"Viel","year":"2002","journal-title":"European journal of pain"},{"key":"10.1016\/j.ahj.2021.05.015_bib0010","first-page":"5","article-title":"Comparison of phenol and alcohol neurolysis of tibial nerve motor branches to the gastrocnemius muscle for treatment of spastic foot after stroke: a randomized controlled pilot study","volume":"46","author":"Kocabas","year":"2010","journal-title":"Eur J Phys Rehabil Med"},{"key":"10.1016\/j.ahj.2021.05.015_bib0011","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1055\/s-0029-1214868","article-title":"Complication rates of EUS-guided celiac plexus blockade and neurolysis: results of a large case series","volume":"41","author":"O'Toole","year":"2009","journal-title":"Endoscopy"},{"key":"10.1016\/j.ahj.2021.05.015_bib0012","doi-asserted-by":"crossref","first-page":"E63","DOI":"10.1111\/papr.12107","article-title":"Bedside ultrasound-guided celiac plexus neurolysis in upper abdominal cancer patients: a randomized, prospective study for comparison of percutaneous bilateral paramedian vs unilateral paramedian needle insertion technique","volume":"14","author":"Bhatnagar","year":"2014","journal-title":"Pain Pract"},{"key":"10.1016\/j.ahj.2021.05.015_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/327036","article-title":"Endoscopic ultrasound-guided celiac plexus neurolysis in pancreatic cancer: a prospective pilot study of safety using 10 mL vs 20 mL alcohol","author":"Leblanc","year":"2013","journal-title":"Diagn Ther Endosc"},{"key":"10.1016\/j.ahj.2021.05.015_bib0014","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1148\/rg.316115526","article-title":"CT-guided celiac plexus neurolysis: a review of anatomy, indications, technique, and tips for successful treatment","volume":"31","author":"Kambadakone","year":"2011","journal-title":"Radiographics"},{"key":"10.1016\/j.ahj.2021.05.015_bib0015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4244\/EIJV9I1A20","article-title":"Ethanol-mediated perivascular renal sympathetic denervation: preclinical validation of safety and efficacy in a porcine model","volume":"9","author":"Fischell","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2021.05.015_bib0016","doi-asserted-by":"crossref","first-page":"e1898","DOI":"10.4244\/EIJ-D-16-00206","article-title":"Randomised, blinded and controlled comparative study of chemical and radiofrequency-based renal denervation in a porcine model","volume":"12","author":"Bertog","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2021.05.015_bib0017","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jcin.2015.11.041","article-title":"Transcatheter Alcohol-Mediated Perivascular Renal Denervation With the Peregrine System: First-in-Human Experience","volume":"9","author":"Fischell","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2021.05.015_bib0018","first-page":"471","article-title":"Alcohol-mediated renal denervation using the Peregrine System Infusion Catheter for treatment of hypertension","volume":"13","author":"Mahfoud","year":"2020","journal-title":"JACC"},{"key":"10.1016\/j.ahj.2021.05.015_bib0019","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.carrev.2015.04.008","article-title":"Next generation renal denervation: chemical \"perivascular\" renal denervation with alcohol using a novel drug infusion catheter","volume":"16","author":"Fischell","year":"2015","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.ahj.2021.05.015_bib0020","unstructured":"Guideline on clinical investigation of medicinal products in the treatment of hypertension.European Medicines Agency. 2016. Available at : https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-clinical-investigation-medicinal-products-treatment-hypertension-revision-4_en.pdf Last accessed October 2020."},{"key":"10.1016\/j.ahj.2021.05.015_bib0021","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/jch.12936","article-title":"Quality of life and emotional impact of a fixed-dose combination of antihypertensive drugs in patients with uncontrolled hypertension","volume":"19","author":"Schmieder","year":"2017","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.ahj.2021.05.015_bib0022","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/(SICI)1097-0258(19990615)18:11<1341::AID-SIM129>3.0.CO;2-7","article-title":"Combining mortality and longitudinal measures in clinical trials","volume":"18","author":"Finkelstein","year":"1999","journal-title":"Statistics in medicine"},{"key":"10.1016\/j.ahj.2021.05.015_bib0023","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/eurheartj\/ehr352","article-title":"The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities","volume":"33","author":"Pocock","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.05.015_bib0024","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/eurheartj\/ehv192","article-title":"Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design","volume":"36","author":"Mahfoud","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.05.015_bib0025","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/eurheartj\/ehx215","article-title":"Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future","volume":"38","author":"Mahfoud","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.05.015_bib0026","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/eurheartj\/ehaa121","article-title":"Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies","volume":"41","author":"Mahfoud","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.05.015_bib0027","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial","volume":"376","author":"Esler","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2021.05.015_bib0028","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0140-6736(13)62192-3","article-title":"Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study","volume":"383","author":"Krum","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2021.05.015_bib0029","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension,(SYMPLICITY HTN-3)","volume":"370","author":"Bhatt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2021.05.015_bib0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/eurheartj\/ehu441","article-title":"Predictors of blood pressure response in the SYMPLICITY HTN-3 trial","volume":"36","author":"Kandzari","year":"2015","journal-title":"Eur Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870321001447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870321001447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:58:05Z","timestamp":1762077485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870321001447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":30,"alternative-id":["S0002870321001447"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2021.05.015","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2021.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}